Arkolith/Insider Trading/APGE/Form 4

Henderson Michael Thomas

Chief Executive Officer, DirectorApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Apr 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2026Sell(S)18K$82.48$1.5M1.1M
Apr 8, 2026Sell(S)2K$83.26$167K1.1M
Apr 8, 2026Sell(S)200$85.00$17K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-042155) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML